Zentiva (BSE:SCD) Change In Receivables : lei-135 Mil (TTM As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Zentiva Change In Receivables?

Zentiva's change in receivables for the quarter that ended in Dec. 2024 was lei49 Mil. It means Zentiva's Accounts Receivable declined by lei49 Mil from Sep. 2024 to Dec. 2024 .

Zentiva's change in receivables for the fiscal year that ended in Dec. 2024 was lei-135 Mil. It means Zentiva's Accounts Receivable increased by lei135 Mil from Dec. 2023 to Dec. 2024 .

Zentiva's Accounts Receivable for the quarter that ended in Dec. 2024 was lei552 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zentiva's Days Sales Outstanding for the three months ended in Dec. 2024 was 174.42.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zentiva's liquidation value for the three months ended in Dec. 2024 was lei260 Mil.

Zentiva Change In Receivables Historical Data

The historical data trend for Zentiva's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva Change In Receivables Chart

Zentiva Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

46.88

144.38

-63.23

-252.63

-134.53

Zentiva Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-92.31	-74.88	-6.05	-102.76	49.16

Zentiva Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-135 Mil.

Zentiva (BSE:SCD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zentiva's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	552.115	/	288.843	*	91
=	174.42

2. In Ben Graham's calculation of liquidation value, Zentiva's accounts receivable are only considered to be worth 75% of book value:

Zentiva's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	33.625	-	284.651	+	0.75 * 552.115	+	0.5 * 192.971
=	260

Zentiva Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zentiva's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentiva Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266

Website

https://www.zentiva.ro

Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.